InvestorsHub Logo
Followers 57
Posts 3275
Boards Moderated 0
Alias Born 03/06/2013

Re: nvok post# 7093

Tuesday, 01/10/2017 1:56:29 PM

Tuesday, January 10, 2017 1:56:29 PM

Post# of 8299
They only need to be successful on one endpoint and the FDA will approve it. They also had control over the patients they enrolled in this study and they seem to have done what worked for phase 2. I'm really hoping for some good news and feel about 80% sure the data will pass for the FDA needs. All IMO, but the company seems confident and I do like the insiders acquiring shares as well as institutes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TENX News